Mitsubishi UFJ Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $339M | Buy |
14,060,742
+1,098,549
| +8% | +$28.7M | 0.19% | 96 |
|
|
2026
Q1 | $364M | Buy |
12,962,193
+880,811
| +7% | +$23.5M | 0.24% | 83 |
|
|
2025
Q4 | $304M | Buy |
12,081,382
+685,111
| +6% | +$17.3M | 0.21% | 95 |
|
|
2025
Q3 | $290M | Buy |
11,396,271
+464,449
| +4% | +$11.5M | 0.21% | 96 |
|
|
2025
Q2 | $265M | Buy |
10,931,822
+775,358
| +8% | +$18.1M | 0.21% | 94 |
|
|
2025
Q1 | $257M | Buy |
10,156,464
+1,143,457
| +13% | +$29.9M | 0.24% | 87 |
|
|
2024
Q4 | $240M | Buy |
9,013,007
+674,556
| +8% | +$18.3M | 0.23% | 87 |
|
|
2024
Q3 | $241M | Buy |
8,338,451
+793,394
| +11% | +$23.1M | 0.26% | 83 |
|
|
2024
Q2 | $211M | Buy |
7,545,057
+760,087
| +11% | +$20.9M | 0.26% | 80 |
|
|
2024
Q1 | $188M | Buy |
6,784,970
+1,167,052
| +21% | +$32.4M | 0.26% | 80 |
|
|
2023
Q4 | $167M | Buy |
5,617,918
+363,931
| +7% | +$11M | 0.29% | 73 |
|
|
2023
Q3 | $174M | Buy |
5,253,987
+405,581
| +8% | +$14.3M | 0.35% | 60 |
|
|
2023
Q2 | $178M | Buy |
4,848,406
+376,893
| +8% | +$14.7M | 0.37% | 57 |
|
|
2023
Q1 | $182M | Buy |
4,471,513
+433,816
| +11% | +$18.7M | 0.43% | 50 |
|
|
2022
Q4 | $207M | Buy |
4,037,697
+458,280
| +13% | +$22M | 0.56% | 42 |
|
|
2022
Q3 | $157M | Buy |
3,579,417
+342,948
| +11% | +$16.7M | 0.5% | 46 |
|
|
2022
Q2 | $170M | Buy |
3,236,469
+285,521
| +10% | +$14.5M | 0.75% | 20 |
|
|
2022
Q1 | $153M | Buy |
2,950,948
+256,041
| +10% | +$13.3M | 0.6% | 26 |
|
|
2021
Q4 | $153M | Buy |
2,694,907
+373,546
| +16% | +$18.5M | 0.61% | 22 |
|
|
2021
Q3 | $99.8M | Buy |
2,321,361
+226,954
| +11% | +$10.1M | 0.49% | 34 |
|
|
2021
Q2 | $82M | Buy |
2,094,407
+230,625
| +12% | +$8.97M | 0.45% | 42 |
|
|
2021
Q1 | $67.5M | Buy |
1,863,782
+207,739
| +13% | +$7.38M | 0.44% | 44 |
|
|
2020
Q4 | $61M | Sell |
1,656,043
-15,323
| -0.9% | -$562K | 0.47% | 43 |
|
|
2020
Q3 | $58.2M | Buy |
1,671,366
+167,276
| +11% | +$5.86M | 0.54% | 38 |
|
|
2020
Q2 | $46.7M | Buy |
1,504,090
+248,277
| +20% | +$8.43M | 0.53% | 40 |
|
|
2020
Q1 | $38.9M | Buy |
1,255,813
+30,278
| +2% | +$1.03M | 0.6% | 33 |
|
|
2019
Q4 | $45.3M | Buy |
1,225,535
+136,050
| +12% | +$4.85M | 0.59% | 35 |
|
|
2019
Q3 | $37.1M | Buy |
1,089,485
+41,027
| +4% | +$1.49M | 0.6% | 38 |
|
|
2019
Q2 | $43.1M | Buy |
1,048,458
+167,696
| +19% | +$6.66M | 0.74% | 28 |
|
|
2019
Q1 | $35.5M | Buy |
880,762
+42,947
| +5% | +$1.72M | 0.73% | 30 |
|
|
2018
Q4 | $33.4M | Sell |
837,815
-51,622
| -6% | -$2.14M | 0.84% | 21 |
|
|
2018
Q3 | $37.2M | Sell |
889,437
-27,032
| -3% | -$1.04M | 0.76% | 24 |
|
|
2018
Q2 | $31.5M | Sell |
916,469
-4,825
| -0.5% | -$165K | 0.7% | 28 |
|
|
2018
Q1 | $31M | Sell |
921,294
-74,465
| -7% | -$2.56M | 0.72% | 27 |
|
|
2017
Q4 | $34.7M | Buy |
995,759
+16,443
| +2% | +$561K | 0.75% | 27 |
|
|
2017
Q3 | $33.2M | Buy |
979,316
+40,588
| +4% | +$1.3M | 0.78% | 28 |
|
|
2017
Q2 | $29.9M | Sell |
938,728
-119,613
| -11% | -$3.77M | 0.73% | 27 |
|
|
2017
Q1 | $34.4M | Buy |
1,058,341
+37,336
| +4% | +$1.18M | 0.78% | 26 |
|
|
2016
Q4 | $32M | Buy |
1,021,005
+21,108
| +2% | +$644K | 0.78% | 27 |
|
|
2016
Q3 | $32.1M | Sell |
999,897
-7,324
| -0.7% | -$245K | 0.8% | 26 |
|
|
2016
Q2 | $33.6M | Buy |
1,007,221
+27,251
| +3% | +$870K | 0.88% | 22 |
|
|
2016
Q1 | $27.6M | Buy |
979,970
+65,514
| +7% | +$1.87M | 0.75% | 29 |
|
|
2015
Q4 | $28M | Buy |
914,456
+56,199
| +7% | +$1.77M | 0.81% | 27 |
|
|
2015
Q3 | $25.6M | Sell |
858,257
-2,082
| -0.2% | -$66.8K | 0.81% | 27 |
|
|
2015
Q2 | $27.4M | Sell |
860,339
-68,847
| -7% | -$2.24M | 0.84% | 23 |
|
|
2015
Q1 | $30.7M | Sell |
929,186
-27,447
| -3% | -$873K | 0.91% | 23 |
|
|
2014
Q4 | $28.4M | Sell |
956,633
-131,478
| -12% | -$3.77M | 0.88% | 16 |
|
|
2014
Q3 | $30.5M | Sell |
1,088,111
-278,918
| -20% | -$7.83M | 0.92% | 15 |
|
|
2014
Q2 | $38.5M | Sell |
1,367,029
-25,653
| -2% | -$731K | 0.99% | 12 |
|
|
2014
Q1 | $42.4M | Sell |
1,392,682
-31,776
| -2% | -$947K | 1.13% | 12 |
|
|
2013
Q4 | $41.2M | Sell |
1,424,458
-262,123
| -16% | -$7.63M | 1.18% | 11 |
|
|
2013
Q3 | $45.9M | Buy |
1,686,581
+51,211
| +3% | +$1.39M | 1.2% | 9 |
|
|
2013
Q2 | $43.5M | Buy |
+1,635,370
| New | +$45.2M | 1.24% | 12 |
|
Other funds holding PFE
Mitsubishi UFJ Asset Management's PFE Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Pfizer (PFE) stake by 8.5% in Q2 2026, buying an estimated $28.7M and bringing the position to 14,060,742 shares worth $339M. The position accounts for 0.19% of the portfolio, ranked #96.
Mitsubishi UFJ Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $364M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Mitsubishi UFJ Asset Management held 14,060,742 shares of Pfizer worth $339M as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 1,098,549 Pfizer shares in Q2 2026, an estimated $28.7M.
- Pfizer made up 0.19% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #96 holding.
- Mitsubishi UFJ Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Mitsubishi UFJ Asset Management's Pfizer position peaked at $364M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.